CIK 0001818331 · Large accelerated filer
GeneDx Holdings Corp.
Sign in to watch- Ticker
- WGS
- Exchange
- Nasdaq
- Industry
- Services-Health Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851966622
- Phone
- 888-729-1206
- Business address
- 333 LUDLOW STREET, NORTH TOWER, 6TH FLOOR, STAMFORD, CT, 06902
- Former names
- Sema4 Holdings Corp., CM Life Sciences, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,839,245
- in 5 filings
Net −$1,839,245. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-04 | Dechairo Bryan Chief Operating Officer | Sale 10b5-1 | −623 | $86.35 | $54K | 2,100 |
| 2026-02-04 | Dechairo Bryan Chief Operating Officer | Sale 10b5-1 | −1,572 | $87.66 | $138K | 528 |
| 2026-02-04 | Dechairo Bryan Chief Operating Officer | Sale 10b5-1 | −328 | $88.66 | $29K | 200 |
| 2026-02-04 | Dechairo Bryan Chief Operating Officer | Sale 10b5-1 | −100 | $90.45 | $9K | 100 |
| 2026-02-04 | Dechairo Bryan Chief Operating Officer | Sale 10b5-1 | −100 | $91.92 | $9K | 0 |
| 2026-02-02 | Dechairo Bryan Chief Operating Officer | Sale | −93 | $96.77 | $9K | 9,281 |
| 2026-02-02 | Dechairo Bryan Chief Operating Officer | Sale | −492 | $98.61 | $49K | 8,789 |
| 2026-02-02 | Dechairo Bryan Chief Operating Officer | Sale | −1,662 | $99.40 | $165K | 7,127 |
| 2026-02-02 | Dechairo Bryan Chief Operating Officer | Sale | −1,166 | $100.31 | $117K | 5,961 |
| 2026-02-01 | Dechairo Bryan Chief Operating Officer | Option exercise | +9,374 | 9,374 | ||
| 2026-02-01 | Dechairo Bryan Chief Operating Officer | Option exercise · Restricted Stock Unit | −9,374 | 28,123 | ||
| 2026-01-29 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise | +754 | 9,485 | ||
| 2026-01-29 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −315 | $94.00 | $30K | 9,170 |
| 2026-01-29 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −2 | $92.06 | $184 | 9,168 |
| 2026-01-29 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit | −754 | 754 | ||
| 2026-01-29 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Option exercise | +3,874 | 18,111 | ||
| 2026-01-29 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Sale | −1,653 | $94.00 | $155K | 16,458 |
| 2026-01-29 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Option exercise · Restricted Stock Unit | −3,874 | 3,874 | ||
| 2025-12-16 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise | +7,197 | 12,586 | ||
| 2025-12-16 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −131 | $138.93 | $18K | 12,455 |
Page 9 of 23 · 450 trades